Tell us again when Koos is going to start fda approved approved clinical trials? Koos’ partner, oncofakeapharma, has all but abandoned trying to get the iP it licensed from deadbeat Dave into preclinical testing. And have you seen onco’s share price? Regen’s remaining shares in the company are pretty much worthless as there is no way Dave can use them as any type of payment,
Maybe the new Cso will be able to work his magic! Oh wait, David hasn’t found a cso. But wait, the cfo will adeptly guide the company during these turbulent times! Oh wait, regen doesn’t have a cfo.
Maybe deadbeat Dave will hire his bro, dr. Brian Koos, to also be the cfo.
News 
Market Data 
Discover 
